This review highlights engineered EVs' therapeutic potential in arthritic diseases, suggesting innovative strategies for OA treatment.
Key Points
Engineered extracellular vesicles show promise in treating arthritic diseases, particularly osteoarthritis, as they offer innovative therapeutic approaches.
Clinical studies confirm that extracellular vesicles significantly improve treatment outcomes for joint diseases, enhancing therapy compared to natural parental stem cells.
Analysis of preclinical trials and in vivo reports reveals that engineered EVs can influence inflammation, cartilage regeneration, and bone remodeling processes.
Understanding the engineering of extracellular vesicles can lead to the development of effective therapies for arthritic diseases and related conditions.